Plutux
IBBEquity

iShares Biotechnology ETF

$213.81

 

52-week range

Twelve months

Assets under management
$10.7B
Expense ratio
0.44%
Holdings
247
NAV
$213.81
Inception
Feb 4, 2001
Issuer
IShares
Asset class
Equity
Exchange
Average volume
1.5M
Volume
50-day average
200-day average
Day range
Previous close
Domicile
US
Official page
ishares.com

About this fund

The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.

Sector exposure

  • Healthcare100.00%

Top holdings

Largest positions by weight. Each links to its own stock page.

Similar funds

All ETFs

Questions

What does IBB hold?

IBB is iShares Biotechnology ETF, run by IShares and listed in the US. It currently holds 247 positions; the largest are AMGN, VRTX, GILD.

What is the expense ratio of IBB?

IBB charges 0.44% per year. The fee is taken out of the fund's assets, so it shows up as a small drag on performance rather than as a separate bill.

How large is IBB?

The fund manages $10.7B. Size matters mainly for liquidity: larger funds tend to trade with tighter spreads and are less likely to be closed by the issuer.

How do I research what is inside IBB?

The holdings list on this page links every position to its own Plutux stock page, where you get the company's price history, financials and AI analysis.

Market data is provided for information only and is not investment advice. Figures can be delayed or restated by the data provider.

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026